Advancing ketamine in the treatment hierarchy for refractory depression.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39449651.
- Also identified by DOI 10.1192/bjp.2024.217.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for refractory depression. This, combined with data on psychiatric treatment outcome mediators, suggests that earlier intervention with ketamine could improve outcomes for patients suffering from refractory depression.
Medical subject headings
- Ketamine
- Depressive Disorder, Treatment-Resistant
- Antidepressive Agents